Analyst Reco. Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 09:06:48 2025-12-16 am EST			5-day change	1st Jan Change
322.25 ^CHF	+0.11%		+2.32%	+26.26%

02:35am	AstraZeneca and Daiichi Sankyo's Enhertu approved as first-line therapy for HER2+ breast cancer
02:35am	AstraZeneca, Daiichi Sankyo Drug Gets U.S. Nod for Breast-Cancer Label Expansion	DJ

Analyst Reco.

ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating	Dec. 15	ZD
ROCHE HOLDINGS AG : Deutsche Bank remains Neutral	Dec. 12	ZD
ROCHE HOLDINGS AG : Goldman Sachs reiterates its Sell rating	Dec. 11	ZD
ROCHE HOLDINGS AG : Receives a Buy rating from UBS	Dec. 11	ZD
Roche Kept at Buy as BofA Notes 'Positive' Late-stage Pipeline Data	Dec. 11	MT
ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating	Dec. 11	ZD
ROCHE HOLDINGS AG : Jefferies remains a Sell rating	Dec. 11	ZD
Swiss stocks - Factors to watch on December 9	Dec. 09	RE
Brightening Consumer Sentiment Lifts Swiss Market Index	Dec. 08	MT
ROCHE HOLDINGS AG : JP Morgan Upgrades to Neutral	Dec. 08	ZD
Swiss stocks - Factors to watch on December 8	Dec. 08	RE
ROCHE HOLDINGS AG : Gets a Buy rating from UBS	Dec. 05	ZD
Berenberg Ups Roche Price Target Amid Upside Pipeline Surprise, Expected 'Solid' Momentum	Dec. 02	MT
ROCHE HOLDINGS AG : Berenberg reiterates its Neutral rating	Dec. 01	ZD
ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating	Nov. 19	ZD
ROCHE HOLDINGS AG : UBS maintains a Buy rating	Nov. 19	ZD
Swiss Market Index Closes Lower; Roche Shares Up	Nov. 18	MT
ROCHE HOLDINGS AG : Jefferies maintains a Sell rating	Nov. 18	ZD
ROCHE HOLDINGS AG : Jefferies reaffirms its Sell rating	Nov. 18	ZD
ROCHE HOLDINGS AG : Deutsche Bank is Neutral	Nov. 12	ZD
Health Care Up as Roche Gains on Drug Progress -- Health Care Roundup	Nov. 10	DJ
ROCHE HOLDINGS AG : UBS gives a Buy rating	Nov. 10	ZD
ROCHE HOLDINGS AG : Sell rating from Jefferies	Nov. 10	ZD
ROCHE HOLDINGS AG : Sell rating from JP Morgan	Nov. 10	ZD
America's markets lose their nerve	Nov. 07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : Markets need more proof of potential; guidance upgrade apparently won't cut it

October 23, 2025 at 11:05 am EDT

Roche will invest $50bn in US over five years.

April 22, 2025 at 04:49 am EDT

Roche CEO 'Very Confident' on Outlook, Momentum

October 23, 2024 at 04:07 am EDT